{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:51:37Z","timestamp":1763725897141,"version":"3.44.0"},"reference-count":26,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2001,11,11]]},"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate depot medroxyprogesterone (DMPA)-associated bone loss in a general practice setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Forty-eight patients from a single practice who had used DMPA for contraception for more than 2 years. All patients had a serum oestradiol and if the serum level was &lt;52 pmol\/l or &gt;52 pmol\/l with menopausal symptoms, bone mineral densitometry (BMD) measurements were made at the lumbar spine (LS) and femoral neck (FN) using dual-energy x-ray absorptiometry (DEXA). Thirty-two patients had bone densitometry, of whom 27 had a serum oestradiol &lt;52 pmol\/l and five &gt;52 pmol\/l associated with menopausal symptoms. Of the remaining 16 patients, nine patients had a serum oestradiol &lt;52 pmol\/l but did not have a BMD as they moved away (five women) or switched to another contraceptive (four women).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>BMD results showed a significantly reduced bone mass at both sites with mean Z score LS -0.84 (95% CI -1.17 to -0.52) and FN -0.32 (95% CI -0.62 to -0.02). Eighteen women (56% of 32 women) had either osteopenia (15 cases) (T score &lt; -1.0) or osteoporosis (three cases) (T score &lt; -2.5) at the LS. There were trends to an association of a family history of height loss or tobacco smoking (current or past) for LS and FN Z scores that did not quite achieve significance. There was also a trend to lower body weight in those with a possible family history of osteoporosis or who were smokers and an inverse correlation of weight with BMD at the FN (p &lt; 0.05) and a non-significant inverse correlation at the LS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The present results demonstrate that a low bone mass should be considered in patients with prolonged DMPA usage especially if they have risk factors for osteoporosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1783\/147118902101195938","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T01:30:57Z","timestamp":1109986257000},"page":"12-15","source":"Crossref","is-referenced-by-count":8,"title":["Depot medroxyprogesterone and bone mineral density"],"prefix":"10.1136","volume":"28","author":[{"given":"P J","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S P","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Guillebaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2002,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.301.6751.516","article-title":"Menstrual state and exercise as determinants of spinal trabecular bone density in female athletes","volume":"301","author":"Wolman, R.L.; Clark, P.; McMally, E.; Harries, M.; Reeve, J.","year":"1990","unstructured":"Wolman RL, Clark P, McMally E, Harries M, Reeve J. Menstrual state and exercise as determinants of spinal trabecular bone density in female athletes. BMJ 1990; 301: 516\u2013518.","journal-title":"BMJ"},{"key":"ref_2","first-page":"311","article-title":"Irreversible bone loss in former amenorrhoeic athletes","volume":"3","author":"Kenn, A.D.; Drinkwater, B.L.","year":"1997","unstructured":"Kenn AD, Drinkwater BL. Irreversible bone loss in former amenorrhoeic athletes. Osteoporosis Int 1997; 3: 311\u2013315.","journal-title":"Osteoporosis Int"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/jbmr.5650071215","article-title":"Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use and exercise","volume":"7","author":"Seeman, E.; Szmukler, G.I.; Formica, C.; Tslamandris, C.; Mestrovic, R.","year":"1992","unstructured":"Seeman E, Szmukler GI, Formica C, Tslamandris C, Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use and exercise. J Bone Miner Res 1992; 7: 1467\u20131474.","journal-title":"J Bone Miner Res"},{"key":"ref_4","first-page":"790","article-title":"Bone mass reduction after estrogen deprivation by long acting gonadotrophin-releasing hormone agonists and its relation to pretreatment concentrations of 1,25 dihydroxyvitamin D3","volume":"70","author":"Scharla, S.H.; Minne, H.W.; Waibel-Treber, S.","year":"1990","unstructured":"Scharla SH, Minne HW, Waibel-Treber S, et al. Bone mass reduction after estrogen deprivation by long acting gonadotrophin-releasing hormone agonists and its relation to pretreatment concentrations of 1,25 dihydroxyvitamin D3. J Clin Endocrinol Metab 1990; 70; 790\u2013793.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/bmj.301.6755.790","article-title":"Bone mineral loss in young women with amenorrhoea","volume":"301","author":"Davies, M.C.; Hall, M.L.; Jacobs, H.S.","year":"1990","unstructured":"Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhoea. BMJ 1990; 301: 790\u2013793.","journal-title":"BMJ"},{"key":"ref_6","first-page":"692","article-title":"Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhoea","volume":"75","author":"Biller, B.M.K.; Baum, H.B.; Rosenthall, D.I.","year":"1992","unstructured":"Biller BMK, Baum HB, Rosenthall DI, et al. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhoea. J Clin Endocrinol 1992; 75: 692\u2013697.","journal-title":"J Clin Endocrinol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","article-title":"Bone density in women receiving depot medroxyprogesterone acetate for contraception","volume":"303","author":"Cundy, T.; Evans, M.; Roberts, H.","year":"1991","unstructured":"Cundy T, Evans M, Roberts H, et al. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 1991; 303: 13\u201316.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bmj.303.6800.467-c","article-title":"DMPA and bone density","volume":"303","author":"Correspondence","year":"1991","unstructured":"Correspondence. DMPA and bone density. BMJ 1991; 303: 467\u2013468.","journal-title":"BMJ"},{"key":"ref_9","first-page":"247","article-title":"Recovery of bone density in women receiving depot medroxyprogesterone acetate for contraception","volume":"308","author":"Cundy, T.; Cornish, J.; Evans, M.C.; Roberts, H.; Reid, I.R.","year":"1993","unstructured":"Cundy T, Cornish J, Evans MC, Roberts H, Reid IR. Recovery of bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 1993; 308: 247\u2013248.","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1471-0528.1998.tb10211.x","article-title":"Bone density in long term users of depot medroxyprogesterone acetate","volume":"105","author":"Gbolade, B.; Ellis, S.; Murby, B.; Randall, S.; Kirkman, R.","year":"1998","unstructured":"Gbolade B, Ellis S, Murby B, Randall S, Kirkman R. Bone density in long term users of depot medroxyprogesterone acetate. Br J Obstet Gynaecol 1998; 105: 790\u2013794.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(97)00066-8","article-title":"Bone mineral density in long term depot medroxyprogesterone acetate acceptors","volume":"56","author":"Taneepanichskul, S.; Intaraprasert, S.; Theppisai, U.; Chaturachinda, K.","year":"1997","unstructured":"Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K. Bone mineral density in long term depot medroxyprogesterone acetate acceptors. Contraception 1997; 56: 1\u20133.","journal-title":"Contraception"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults","volume":"8","author":"Looker, A.C.; Wahner, H.W.; Dunn, W.L.","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporosis Int 1998; 8: 468\u2013489.","journal-title":"Osteoporosis Int"},{"key":"ref_13","first-page":"2","article-title":"Statistical Bulletin Metropolitan Life Foundation","volume":"64","year":"1983","unstructured":"Statistical Bulletin Metropolitan Life Foundation. 1983; 64: 2\u20139."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/31.12.823","article-title":"Post menopausal screening for osteopaenia","volume":"31","author":"Ryan, P.J.; Blake, G.M.; Fogelman, I.","year":"1992","unstructured":"Ryan PJ, Blake GM, Fogelman I. Post menopausal screening for osteopaenia. Br J Rheumatol 1992; 31: 823\u2013828.","journal-title":"Br J Rheumatol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2265.1998.00582.x","article-title":"The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal postmenopausal women","volume":"49","author":"Orr-Walker, B.J.; Evans, M.C.; Ames, R.W.","year":"1998","unstructured":"Orr-Walker BJ, Evans MC, Ames RW, et al. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal postmenopausal women. Clin Endocrinol 1998; 49: 615\u2013618.","journal-title":"Clin Endocrinol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0010-7824(98)00125-5","article-title":"Bone density among long term users of medroxyprogesterone acetate as a contraceptive","volume":"58","author":"L, Costa Paiva; AM, Pinto-Neto; A, Faundes","year":"1998","unstructured":"Costa Paiva L, Pinto-Neto AM, Faundes A. Bone density among long term users of medroxyprogesterone acetate as a contraceptive. Contraception 1998; 58: 351\u2013355.","journal-title":"Contraception"},{"key":"ref_17","first-page":"274","article-title":"Spinal bone density in women using depot medroxyprogesterone contraception","volume":"1","author":"Cundy, T.; Cornish, J.; Evans, M.C.; Holmes, H.; Reid, I.R.","year":"1996","unstructured":"Cundy T, Cornish J, Evans MC, Holmes H, Reid IR. Spinal bone density in women using depot medroxyprogesterone contraception. Osteoporosis Int 1996; 6 (Suppl. 1): 274.","journal-title":"Osteoporosis Int"},{"key":"ref_18","first-page":"1010","article-title":"Short term effects of high dose oral medroxyprogesterone in pre menopausal women","volume":"81","author":"Cundy, T.; Farquhar, C.M.; Cornish, J.; Reid, I.R.","year":"1996","unstructured":"Cundy T, Farquhar CM, Cornish J, Reid IR. Short term effects of high dose oral medroxyprogesterone in pre menopausal women. J Clin Endocrinol Metab 1996; 81: 1010\u20131017.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_19","first-page":"221","article-title":"Bone density in long-term DMPA users: a double blind randomised controlled trial of estrogen replacement therapy","volume":"(Suppl.):","author":"Cundy, T.; Ames, R.; Clearwater, J.","year":"2001","unstructured":"Cundy T, Ames R, Clearwater J, et al. Bone density in long-term DMPA users: a double blind randomised controlled trial of estrogen replacement therapy. J Bone Miner Res 2001; 16 (Suppl.): S221.","journal-title":"J Bone Miner Res"},{"key":"ref_20","first-page":"849","article-title":"Forearm bone density in users of Depo Provera as a contraceptive method","volume-title":"Fertil Steril","volume":"71","author":"Bahamondes, L.; Perrotti, M.; Castro, S.; Faundes, D.; Petta, C.; Bedsone, A.","year":"1999","unstructured":"Bahamondes L, Perrotti M, Castro S, Faundes D, Petta C, Bedsone A. Forearm bone density in users of Depo Provera as a contraceptive method. Fertil Steril 1999; 71: 849\u2013852."},{"key":"ref_21","first-page":"736","article-title":"for the WHO study of hormone contraception and bone health. Steroid hormone contraception and bone mineral density: a cross sectional study in an international population","volume":"95","author":"Petitti, D.B.; Piaggio, G.; Mehta, S.; Cravioto, M.C.; Meirik, O.","year":"2000","unstructured":"Petitti DB, Piaggio G, Mehta S, Cravioto MC, Meirik O, for the WHO study of hormone contraception and bone health. Steroid hormone contraception and bone mineral density: a cross sectional study in an international population. Obstet Gynaecol 2000; 95: 736\u2013744.","journal-title":"Obstet Gynaecol"},{"key":"ref_22","first-page":"233","article-title":"Bone mineral density in women using depot medroxyprogesterone acetate for contraception","volume":"93","author":"Scholes, D.; Lacroix, A.Z.; Ott, S.M.; Ichikawa, L.E.; Barlow, W.","year":"1999","unstructured":"Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow W. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynaecol 1999; 93: 233\u2013238.","journal-title":"Obstet Gynaecol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant) or oral contraceptives","volume":"129","author":"Cromer, B.A.; MacArdle Blair, J.; Mahan, J.D.; Zibners, J.D.; Naumovski, Z.","year":"1996","unstructured":"Cromer BA, MacArdle Blair J, Mahan JD, Zibners JD, Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant) or oral contraceptives. J Pediatr 1996; 129: 671\u2013676.","journal-title":"J Pediatr"},{"key":"ref_24","first-page":"235","article-title":"Depot medroxy progesterone acetate and bone mineral density in adolescent women","volume":"1","author":"Scholes, D.; LaCroix, A.; Ichikawa, L.; Barlow, W.; Ott, S.","year":"2001","unstructured":"Scholes D, LaCroix A, Ichikawa L, Barlow W, Ott S. Depot medroxy progesterone acetate and bone mineral density in adolescent women. J Bone Miner Res 2001; 16 (Suppl. 1): S235.","journal-title":"J Bone Miner Res"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0010-7824(95)00121-P","article-title":"Differential effects on bone density of progestogen only methods for contraception in premenopausal women","volume":"52","author":"Naessen, T.; Olsson, S.E.; Gudmundson, J.","year":"1995","unstructured":"Naessen T, Olsson SE, Gudmundson J. Differential effects on bone density of progestogen only methods for contraception in premenopausal women. Contraception 1995; 52: 35\u201339.","journal-title":"Contraception"},{"article-title":"World Health Organization (WHO). Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. WHO\/RHR\/00.02","year":"2001","key":"ref_26","unstructured":"World Health Organization (WHO). Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. WHO\/RHR\/00.02. Geneva: World Health Organization, 2001."}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118902101195938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:57:01Z","timestamp":1756875421000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118902101195938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,1,1]]},"published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1783\/147118902101195938"],"URL":"https:\/\/doi.org\/10.1783\/147118902101195938","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}